HIV POSITIVE  Treatment
Protease Inhibitors  NEW!


Effects of Protease Inhibitors and Other Commonly Used Medications as Determined by Drug Interaction Studies
*Dosage Adjustments should be determined by a physician*


Drug Category: ANTIFUNGALS

Drug Name Invirase™ Roche
saquinavir
Recommend Norvir™ Abbott
ritonavir
Recommend Crixivan® Merck
indinavir
Recommend
Fluconazole (Diflucan) no studies have been conducted - no data available
fluconazole increased ritonavir AUC by 15% no dosage adjustment necessary decreases indinavir AUC by19% +/- 33% no dosage adjustment necessary
Ketoconazole (Nizoral) ketoconazole increased saquinavir AUC and Cmax 3 -fold no dosage adjustment necessary when ketaconazole 200 mg qd and saquinavir 600 mg tid are given no studies have been conducted - no data available
ketoconazole increased indinavir AUC levels by 68+/-48% reduce indinavir to 600 mg q8h


Drug Category: ANTIMYCOBACTERIALS

Drug Name Invirase™ Roche
saquinavir
Recommend Norvir™ Abbott
ritonavir
Recommend Crixivan® Merck
indinavir
Recommend
Clarithromycin (Biaxin) no studies have been conducted - no data available
clarithromycin AUC increased by 77% dosage adjustment to patient with renal impariment is necessary increased indinavir AUC by 29% +/- 42% and increased clarithromycin AUC by 53% +/- 36% no dosage adjustment necessary
Rifabutin (Mycobutin) rifabutin decreased saquinavir levels by 40% if rifabutin therapy is warranted, consider alternative drugs rifabutin AUC increased by 4 fold

rifabutin metabolite (25-0-desacetyl) AUC increased by 35 fold

coadministration of ritonavir and rifabutin is contraindicated rifabutin AUC increased by 204 +/-142% reduce rifabutin to half the standard dose
Rifampin (Rifadin, others) rifampin decreased saquinavir levels by 80% rifampin and saquinavir should not be administered concomitantly rifampin decreased ritonavir levels by 35% no dosage adjustment necessary rifampin decreased AUC of saquinavir by approximately 80% rifampin and indinavir should not be administered concomitantly


Drug Category: ORAL CONTRACEPTIVES

Invirase™ Roche
saquinavir
Recommend Norvir™ Abbott
ritonavir
Recommend Crixivan® Merck
indinavir
Recommend
no studies have been conducted - no data available
ethinyl estradiol AUC decreased by 40% dosage increase or alternate contraceptive measures should be considered Ortho-Novum 1/35 increased ethinyl estradiol 24+/-17% and norethindrone by 26 +/-14% no dosage adjustment necessary


Drug Category: OTHER

Invirase™ Roche
saquinavir
Recommend Norvir™ Abbott
ritonavir
Recommend Crixivan® Merck
indinavir
Recommend
ritonavir markedly increased saquinavir plasma levels
(see ritonavir)
safety of this interaction has not been established desipramine (Norpramin, others) AUC increased by 145%

greater than 20-fold increase in saquinavir AUC

theophylline (Theo-Dur, others) AUC decreased by 43%

tobacco decreased ritonavir AUC by 18%

dosage reduction should be considered

safety of this interaction has not been established

dosage increase may be required

grapefruit juice decreased indinavir levels by 26%


Go to the Backgrounder Page

Go to the Protease Inhibitor Menu

Go to the Treatment Menu

Go to the HIVpositive.us Main Menu













39